Related Experiment Video
Updated: Jun 24, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Hepatotoxicity in an infant following supratherapeutic dosing of acetaminophen for twenty-four hours
Arthur Kubic1, Anthony M Burda, Elizabeth Bockewitz
1Illinois Poison Center, Chicago, Illinois 60606, USA. akubic@ilpoison.org
Insights
Infants may develop severe liver injury from chronic acetaminophen use, even at doses slightly above recommended guidelines. Prompt n-acetylcysteine treatment is crucial for recovery from acetaminophen toxicity.
Area of Science:
- Pediatric Toxicology
- Pharmacovigilance
- Hepatology
Background:
- Acetaminophen overdose in children typically results in mild hepatotoxicity.
- Chronic or repeated high-dose acetaminophen administration poses a significant risk, unlike acute overdose.
Observation:
- A 7-month-old infant received concentrated infant acetaminophen (234 mg/kg/24 hours) for a febrile illness.
- The incorrect dosage was administered for a duration leading to significant liver enzyme elevation.
Findings:
- The infant presented with markedly elevated AST (1339 U/L) and ALT (907 U/L) levels.
- Intravenous n-acetylcysteine therapy led to a rapid decline in liver enzymes within 48 hours.
- This case highlights a rapid onset of acetaminophen-induced hepatotoxicity in an infant.
Implications:
- Even slight deviations from recommended acetaminophen dosages in infants can cause severe liver injury.
- This case underscores the importance of accurate medication dosing and adherence to national triage guidelines for pediatric acetaminophen exposure.
- Early recognition and treatment with n-acetylcysteine are vital for managing acetaminophen toxicity in children.
Abstract:
Severe hepatotoxicity in acute acetaminophen overdose in children is uncommon. This apparent protection does not extend to chronic or repeated high dose acetaminophen administration. The Illinois Poison Center (IPC) was consulted on a case involving a 7 month old 17 lb infant, who had presented the day prior to an emergency department with complaint of febrile illness. Patient had been prescribed acetaminophen for symptoms, and the mother called IPC when she realized that she had been incorrectly giving the patient concentrated infant acetaminophen (80 mg per 0.8 mL) totalling 42.3 mg/kg/dose or 234 mg/kg/24 hours instead of children's acetaminophen (160 mg/5 ml). Per recently published national triage guidelines, the patient was referred to an acute care facility for evaluation. The patient presented with significantly elevated aspartate aminotransferrase (AST) and alanine aminotransferrase (ALT) levels of 1339 and 907 U/L respectively, and was initiated on i.v. n-acetylcysteine therapy. The patient responded well to therapy, with AST and ALT declining to 145 and 479 U/L respectively over the next 48 hours. This case represents one of the shortest durations of chronic acetaminophen therapy to cause hepatic injury in an infant. Further, while the level was only slightly above the national triage guideline recommended referral dose per 24 hours, significant hepatotoxicity was observed.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Dose-Dependent Reactions
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Distribution
